In ovarian cancer, Wang et al. showed that the HOTAIR expression level is higher in late-stage malignant ovarian tissue tumours in vitro cell models resistant to cisplatin treatments compared to the level in early-stage tumours. Here, HOTAIR is linked to ovarian cancer.